10 Best Undervalued Dividend Stocks At 52w High for November 2025
Welcome to the Value Sense Blog, your resource for insights on the stock market! At Value Sense, we focus on intrinsic value tools and offer stock ideas with undervalued companies. Dive into our research products and learn more about our unique approach at valuesense.io
Explore diverse stock ideas covering technology, healthcare, and commodities sectors. Our insights are crafted to help investors spot opportunities in undervalued growth stocks, enhancing potential returns. Visit us to see evaluations and in-depth market research.
Market Overview & Selection Criteria
The 2025 market landscape is shaped by persistent macroeconomic shifts, sector rotation, and a renewed focus on intrinsic value and cash flow resilience. Our stock selection methodology prioritizes companies with strong quality ratings, robust free cash flow, and attractive intrinsic value discounts. We analyze a blend of technology, healthcare, media, energy, and materials stocks, ensuring sectoral diversification and exposure to both growth and value opportunities. Each pick is evaluated using ValueSense’s proprietary ratings, financial metrics, and risk assessments to deliver a balanced, data-driven watchlist.
Featured Stock Analysis
Cisco Systems, Inc. (CSCO)
| Metric | Value |
|---|---|
| Market Cap | $289.5B |
| Quality Rating | 6.6 |
| Intrinsic Value | $78.2 |
| 1Y Return | 34.4% |
| Revenue | $56.7B |
| Free Cash Flow | $13.3B |
| Revenue Growth | 5.3% |
| FCF margin | 23.5% |
| Gross margin | 65.1% |
| ROIC | 13.3% |
| Total Debt to Equity | 63.3% |
Investment Thesis
Cisco Systems stands out as a technology leader with a market cap of $289.5B and a ValueSense quality rating of 6.6. The company’s intrinsic value is estimated at $78.2, suggesting potential upside relative to current market pricing. Cisco’s robust free cash flow of $13.3B and a 1-year return of 34.4% highlight its operational strength and shareholder value creation. With revenue of $56.7B and a healthy gross margin of 65.1%, Cisco demonstrates both scale and profitability. The company’s FCF margin of 23.5% and ROIC of 13.3% further reinforce its capital efficiency.
Key Catalysts
- Continued enterprise and cloud infrastructure demand
- Expansion in cybersecurity and networking solutions
- Strong free cash flow supporting dividends and buybacks
- Margin resilience amid supply chain normalization
Risk Factors
- Exposure to global IT spending cycles
- Competitive pressures from emerging networking technologies
- Elevated total debt to equity 63.3% may limit financial flexibility
Cencora (COR)
| Metric | Value |
|---|---|
| Market Cap | $65.5B |
| Quality Rating | 6.2 |
| Intrinsic Value | $361.5 |
| 1Y Return | 48.8% |
| Revenue | $316.7B |
| Free Cash Flow | $1,141.6M |
| Revenue Growth | 11.6% |
| FCF margin | 0.4% |
| Gross margin | 3.3% |
| ROIC | 16.0% |
| Total Debt to Equity | 372.9% |
Investment Thesis
Cencora, with a $65.5B market cap and a quality rating of 6.2, is a healthcare distribution powerhouse. The company’s intrinsic value of $361.5 signals a favorable valuation backdrop. Cencora’s revenue base is massive at $316.7B, and its 1-year return of 48.8% reflects strong market confidence. While its free cash flow margin is modest at 0.4%, the company’s revenue growth of 11.6% and ROIC of 16.0% indicate operational efficiency and disciplined capital allocation.
Key Catalysts
- Expanding pharmaceutical distribution networks
- Benefiting from healthcare sector growth and demographic trends
- Strategic partnerships and supply chain optimization
Risk Factors
- Low gross margin 3.3% exposes earnings to cost fluctuations
- High total debt to equity 372.9% increases financial risk
- Regulatory changes in healthcare reimbursement
Warner Bros. Discovery, Inc. (WBD)
| Metric | Value |
|---|---|
| Market Cap | $55.6B |
| Quality Rating | 6.1 |
| Intrinsic Value | $26.4 |
| 1Y Return | 176.1% |
| Revenue | $38.4B |
| Free Cash Flow | $4,065.0M |
| Revenue Growth | (3.7%) |
| FCF margin | 10.6% |
| Gross margin | 52.7% |
| ROIC | (12.3%) |
| Total Debt to Equity | 92.7% |
Investment Thesis
Warner Bros. Discovery has experienced a remarkable 1-year return of 176.1%, driven by strategic content investments and streaming growth. With a $55.6B market cap and a quality rating of 6.1, WBD’s intrinsic value of $26.4 suggests further upside potential. The company’s $38.4B in revenue and $4.07B in free cash flow underscore its scale and cash generation, while a gross margin of 52.7% supports profitability in a competitive media landscape.
Key Catalysts
- Growth in direct-to-consumer streaming platforms
- Content library monetization and global expansion
- Cost synergies from recent mergers
Risk Factors
- Negative revenue growth -3.7% signals top-line pressure
- Negative ROIC -12.3% highlights capital allocation challenges
- High leverage (total debt to equity 92.7%)
Vale S.A. (VALE)
| Metric | Value |
|---|---|
| Market Cap | $51.6B |
| Quality Rating | 5.7 |
| Intrinsic Value | $27.8 |
| 1Y Return | 18.2% |
| Revenue | $36.1B |
| Free Cash Flow | $1,956.3M |
| Revenue Growth | (14.1%) |
| FCF margin | 5.4% |
| Gross margin | 34.1% |
| ROIC | 13.1% |
| Total Debt to Equity | 50.1% |
Investment Thesis
Vale S.A. is a global mining leader with a $51.6B market cap and a quality rating of 5.7. Its intrinsic value of $27.8 and a 1-year return of 18.2% reflect its position as a value-oriented commodity play. Vale’s $36.1B in revenue and $1.96B in free cash flow are supported by a 34.1% gross margin and a 5.4% FCF margin. Despite recent revenue contraction -14.1%, Vale’s ROIC of 13.1% and moderate leverage (total debt to equity 50.1%) provide a foundation for recovery.
Key Catalysts
- Global demand for iron ore and base metals
- Operational efficiency improvements
- Potential for dividend growth
Risk Factors
- Commodity price volatility
- Environmental and regulatory risks
- Revenue growth challenges
Cardinal Health, Inc. (CAH)
| Metric | Value |
|---|---|
| Market Cap | $45.4B |
| Quality Rating | 6.9 |
| Intrinsic Value | $208.8 |
| 1Y Return | 76.5% |
| Revenue | $234.3B |
| Free Cash Flow | $4,452.0M |
| Revenue Growth | 4.4% |
| FCF margin | 1.9% |
| Gross margin | 3.7% |
| ROIC | 47.4% |
| Total Debt to Equity | (330.7%) |
Investment Thesis
Cardinal Health, with a $45.4B market cap and a leading quality rating of 6.9, is a key player in healthcare distribution. Its intrinsic value of $208.8 and a 1-year return of 76.5% highlight strong market positioning. Cardinal’s $234.3B in revenue and $4.45B in free cash flow are complemented by a 4.4% revenue growth rate and a 1.9% FCF margin. The company’s ROIC of 47.4% is particularly notable, indicating exceptional capital efficiency.
Key Catalysts
- Expanding healthcare logistics and supply chain services
- Aging population driving demand for medical products
- Operational improvements boosting margins
Risk Factors
- Low gross margin 3.7% limits profitability buffer
- Negative total debt to equity -330.7% may reflect accounting or capital structure complexities
- Regulatory and reimbursement headwinds
Telefonaktiebolaget LM Ericsson (publ) (ERIC)
| Metric | Value |
|---|---|
| Market Cap | $33.6B |
| Quality Rating | 6.2 |
| Intrinsic Value | $16.7 |
| 1Y Return | 20.4% |
| Revenue | SEK 240.3B |
| Free Cash Flow | SEK 30.7B |
| Revenue Growth | (2.6%) |
| FCF margin | 12.8% |
| Gross margin | 46.9% |
| ROIC | 14.6% |
| Total Debt to Equity | 42.9% |
Investment Thesis
Ericsson, with a $33.6B market cap and a quality rating of 6.2, is a global telecom equipment leader. Its intrinsic value of $16.7 and a 1-year return of 20.4% highlight its steady performance. Ericsson’s SEK 240.3B in revenue and SEK 30.7B in free cash flow are supported by a 46.9% gross margin and a 12.8% FCF margin. The company’s ROIC of 14.6% and moderate leverage (total debt to equity 42.9%) indicate balanced financial health.
Key Catalysts
- 5G infrastructure rollouts worldwide
- Strategic partnerships with telecom operators
- Expansion into IoT and enterprise solutions
Risk Factors
- Revenue contraction -2.6% in a competitive market
- Currency and geopolitical risks
- Technology cycle dependencies
Fox Corporation (FOXA)
| Metric | Value |
|---|---|
| Market Cap | $28.9B |
| Quality Rating | 7.3 |
| Intrinsic Value | $111.2 |
| 1Y Return | 54.7% |
| Revenue | $16.5B |
| Free Cash Flow | $2,769.0M |
| Revenue Growth | 14.9% |
| FCF margin | 16.8% |
| Gross margin | 83.4% |
| ROIC | 19.2% |
| Total Debt to Equity | 53.6% |
Investment Thesis
Fox Corporation, with a $28.9B market cap and a top quality rating of 7.3, is a major media and entertainment company. Its intrinsic value of $111.2 and a 1-year return of 54.7% underscore its strong market performance. Fox’s $16.5B in revenue and $2.77B in free cash flow are supported by a 14.9% revenue growth rate and a robust 16.8% FCF margin. The company’s gross margin of 83.4% and ROIC of 19.2% highlight operational excellence.
Key Catalysts
- Growth in digital and streaming platforms
- Strong content portfolio and advertising revenue
- Efficient capital allocation
Risk Factors
- Media industry disruption and competition
- Regulatory and reputational risks
- Moderate leverage (total debt to equity 53.6%)
Fox Corporation (FOX)
| Metric | Value |
|---|---|
| Market Cap | $26.1B |
| Quality Rating | 7.2 |
| Intrinsic Value | $114.6 |
| 1Y Return | 50.7% |
| Revenue | $16.5B |
| Free Cash Flow | $2,907.0M |
| Revenue Growth | 14.9% |
| FCF margin | 17.6% |
| Gross margin | 64.5% |
| ROIC | 18.1% |
| Total Debt to Equity | 53.6% |
Investment Thesis
FOX, the non-voting share class of Fox Corporation, has a $26.1B market cap and a quality rating of 7.2. Its intrinsic value of $114.6 and a 1-year return of 50.7% mirror the company’s strong fundamentals. With $16.5B in revenue and $2.91B in free cash flow, FOX shares the same growth drivers as FOXA, including a 14.9% revenue growth rate and a 17.6% FCF margin. The gross margin of 64.5% and ROIC of 18.1% further support its investment case.
Key Catalysts
- Exposure to the same media and digital growth trends as FOXA
- Attractive free cash flow and margin profile
- Share class structure may offer unique trading dynamics
Risk Factors
- Similar industry and regulatory risks as FOXA
- Share class liquidity and voting rights considerations
Centrais Elétricas Brasileiras S.A. - Eletrobrás (EBR)
| Metric | Value |
|---|---|
| Market Cap | $23.3B |
| Quality Rating | 6.4 |
| Intrinsic Value | $13.0 |
| 1Y Return | 61.2% |
| Revenue | R$43.7B |
| Free Cash Flow | R$13.6B |
| Revenue Growth | 22.0% |
| FCF margin | 31.2% |
| Gross margin | 47.5% |
| ROIC | 12.1% |
| Total Debt to Equity | 61.9% |
Investment Thesis
Eletrobrás is a leading Brazilian utility with a $23.3B market cap and a quality rating of 6.4. Its intrinsic value of $13.0 and a 1-year return of 61.2% highlight its growth potential. Eletrobrás’s R$43.7B in revenue and R$13.6B in free cash flow are supported by a 22.0% revenue growth rate and a 31.2% FCF margin. The company’s gross margin of 47.5% and ROIC of 12.1% indicate solid profitability and capital efficiency.
Key Catalysts
- Expansion of renewable energy and grid modernization
- Strong free cash flow generation
- Supportive regulatory environment in Brazil
Risk Factors
- Currency and political risks in emerging markets
- Infrastructure investment requirements
- Moderate leverage (total debt to equity 61.9%)
Sociedad Química y Minera de Chile S.A. (SQM)
| Metric | Value |
|---|---|
| Market Cap | $14.0B |
| Quality Rating | 5.5 |
| Intrinsic Value | $65.4 |
| 1Y Return | 27.6% |
| Revenue | $4,229.9M |
| Free Cash Flow | ($75.4M) |
| Revenue Growth | (23.5%) |
| FCF margin | (1.8%) |
| Gross margin | 26.8% |
| ROIC | 8.8% |
| Total Debt to Equity | 87.8% |
Investment Thesis
SQM, with a $14.0B market cap and a quality rating of 5.5, is a global leader in lithium and specialty chemicals. Its intrinsic value of $65.4 and a 1-year return of 27.6% reflect its role in the energy transition. SQM’s $4.23B in revenue is challenged by a recent contraction -23.5%, but its gross margin of 26.8% and ROIC of 8.8% support its long-term prospects. The company’s negative free cash flow margin -1.8% and high leverage (total debt to equity 87.8%) warrant careful monitoring.
Key Catalysts
- Rising global demand for lithium in EV batteries
- Expansion into specialty chemicals and fertilizers
- Strategic partnerships with global manufacturers
Risk Factors
- Commodity price volatility and cyclical demand
- Negative free cash flow and revenue contraction
- Regulatory and environmental challenges
Portfolio Diversification Insights
This watchlist spans technology, healthcare, media, energy, utilities, and materials, offering a diversified approach to stock selection. By including both growth and value stocks, as well as U.S. and international companies, the portfolio mitigates sector-specific risks and captures a broad range of macroeconomic drivers. The presence of high free cash flow generators (e.g., Cisco, Fox, Eletrobrás) alongside cyclical and emerging market plays (e.g., Vale, SQM) enhances risk-adjusted return potential.
Market Timing & Entry Strategies
Investors should consider staggered entry points and dollar-cost averaging to manage volatility, especially in sectors exposed to cyclical swings (commodities, media). Monitoring earnings releases, macroeconomic data, and sector rotation trends can help optimize timing. For long-term positions, focusing on intrinsic value gaps and free cash flow resilience provides a margin of safety. Always align entry strategies with individual risk tolerance and investment horizon.
Explore More Investment Opportunities
For investors seeking undervalued companies with high fundamental quality, our analytics team provides curated stock lists:
📌 50 Undervalued Stocks (Best overall value plays for 2025)
📌 50 Undervalued Dividend Stocks (For income-focused investors)
📌 50 Undervalued Growth Stocks (High-growth potential with strong fundamentals)
🔍 Check out these stocks on the Value Sense platform for free!
More Articles You Might Like
- How VKTX (Viking Therapeutics) Makes Money in 2025: A Deep-Dive With Income Statement
- How NET (Cloudflare) Makes Money in 2025: A Deep-Dive With Income Statement
- How MASS (908 Devices) Makes Money in 2025: A Deep-Dive With Income Statement
- How CRVO (CervoMed) Makes Money in 2025: A Deep-Dive With Income Statement
- How GILD (Gilead Sciences) Makes Money in 2025: A Deep-Dive With Income Statement
FAQ Section
Q1: How were these stocks selected?
These stocks were chosen using ValueSense’s intrinsic value models, quality ratings, and a focus on free cash flow, sector diversification, and upside potential based on current financial data.
Q2: What's the best stock from this list?
Each stock offers unique strengths; for example, Fox Corporation (FOXA) has the highest quality rating, while Warner Bros. Discovery (WBD) delivered the strongest 1-year return. The "best" depends on individual investment goals and risk tolerance.
Q3: Should I buy all these stocks or diversify?
Diversification across sectors and geographies can help manage risk. This watchlist is designed to provide a balanced mix, but allocation should be tailored to your personal financial situation.
Q4: What are the biggest risks with these picks?
Key risks include sector-specific volatility, regulatory changes, leverage, and macroeconomic shifts. Each stock’s risk profile is detailed in its analysis section above.
Q5: When is the best time to invest in these stocks?
Optimal timing depends on market conditions, earnings cycles, and individual risk appetite. Consider dollar-cost averaging and monitor intrinsic value gaps for potential entry points.